SCHEMBL9537919

SCHEMBL9537919

Cn1ncc2c1-c1cc(Cl)ccc1N(C(=O)C1CC1)C2

nearest known ligand 0.40

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ AVPR1A P37288 4/20 0.40
▸ BRD4 O60885 2/20 0.39
▸ HSD17B3 P37058 5/20 0.38
▸ MAPT P10636 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ HTR2A P28223 2/20 0.36
▸ HTR2C P28335 2/20 0.36
▸ IDH1 O75874 2/20 0.35
▸ NOTUM Q6P988 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9537279 0.86 ADORA3 (0.43) BRD4HSD17B3KDM4EHTR2AHTR2C
SCHEMBL9535647 0.82 ADORA3 (0.45) BRD4MAPTHTR2AHTR2C
SCHEMBL9535510 0.81 BRD4 (0.37) BRD4HSD17B3HTR2AHTR2C
SCHEMBL9540686 0.79 HTR2A (0.37) AVPR1AHSD17B3KDM4EHTR2AHTR2C
SCHEMBL9535516 0.76 PTK2 (0.34) HTR2AHTR2C
SCHEMBL9537240 0.75 PSEN1 (0.47) AVPR1ABRD4HSD17B3MAPTALDH1A1
SCHEMBL9538216 0.75 PSEN1 (0.37) AVPR1AMAPTALDH1A1RAB9AHTR2A
SCHEMBL2704303 0.75 AVPR1A (0.42) AVPR1AIDH1
SCHEMBL9538692 0.74 ADORA3 (0.42) HSD17B3KDM4ERAB9ANOTUM
SCHEMBL9538271 0.73 ADORA3 (0.40) BRD4HSD17B3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0180352-B1 BENZENE-FUSED HETEROCYCLIC COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-05-26 — — EP disclosed
US-4767780-A SUBSTITUTED 1,4-DIHYDRO-(1)-BENZOPYRANO(4,3-C)PYRAZOLES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-08-30 — — US disclosed
US-4675324-A Substituted pyrazolo [4,3-c]pyridines and their use as uricosuric, diuretic and anti-hypertensive agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-06-23 — — US disclosed
EP-0180352-A2 Benzene-fused heterocyclic compound FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 — — EP disclosed
Send feedback